Vaccination, especially booster doses, reduces the risk of long COVID by up to 29%, highlighting its critical role in preventing lingering Omicron-era complications.
FDA approves Chiesi’s gel for rare skin disease after initial 2022 rejection for Amryt
Certain children with the rare skin disease epidermolysis bullosa now have a treatment option thanks to an FDA approval for Chiesi Global Rare Diseases’ topical
December 20, 2023